Turing Pharmaceuticals

Listing Websites about Turing Pharmaceuticals

Filter Type:

Turing Pharmaceuticals

(2 days ago) Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.WebsiteDirectionsContact usOops! Something went wrong, please try again later.Suggest an edit · Your business? Claim nowSee moreSee all on WikipediaVyera Pharmaceuticals - Wikipediahttps://en.wikipedia.org/wiki/Vyera_PharmaceuticalsTuring Pharmaceuticals was launched in February 2015 by Martin Shkreli with the acquisition of three major assets from an orphan drug developer called Retrophin: an intranasal formulation of ketamine, an oxytocin nasal solution, and Vecamyl. The company acquired the US marketing rights to Daraprim from … See more

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals - Crunchbase Company Profile

(2 days ago) WebPhone Number 1 (646) 356-5577 Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals AG LinkedIn

(5 days ago) WebTuring Pharmaceuticals AG is a privately-held biopharmaceutical company with offices in New York City and Zug, Switzerland. Turing focuses on developing and commercializing innovative

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals CEO Martin Shkreli Arrested for Securities …

(4 days ago) Web-- Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli, who was heavily criticized for raising the price of a drug used to treat a life …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


A Timeline of the Turing Pharma Controversy - Forbes

(8 days ago) WebAug. 10 —Turing announces it has raised $90 million in a Series A financing that included equity and debt. An SEC filing said Turing raised $62.7 million in equity …

Url: Visit Now

Category:  Health Detail Drugs


'Pharma Bro' Martin Shkreli fined $64M, banned from …

(2 days ago) WebIn 2015,Shkreli’s company, Turing Pharmaceuticals, acquired the rights to Daraprim, a life-saving drug that is used to treat infections that occur in patients suffering …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


US pharmaceutical company defends 5,000% price …

(9 days ago) WebTuring Pharmaceuticals boss Martin Shkreli had previously defended the price raise The head of a US pharmaceutical company has defended his company's decision to raise the price of a 62-year-old

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


A Decade Marked By Outrage Over Drug Prices - NPR.org

(6 days ago) WebThe man was Martin Shkreli, the former CEO of Turing Pharmaceuticals, who was called before Cummings' committee in February 2016. After hiking the price of …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


"Pharma Bro" Martin Shkreli charged with fixing price of …

(8 days ago) WebShkreli gained notoriety after a drug company he founded, Turing Pharmaceuticals, spent $55 million for the U.S. rights to sell Daraprim and promptly raised the price about 4,000% to $750 per

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Who is Martin Shkreli - 'the most hated man in America'?

(9 days ago) WebA rocky start in pharmaceuticals Turing was not Mr Shkreli's first foray into the pharmaceutical industry. In 2011, he founded biotech firm Retrophin, with the goal of focusing on medicines for

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Martin Shkreli - Wikipedia

(4 days ago) WebTuring Pharmaceuticals [ edit] Shkreli founded Turing Pharmaceuticals in February 2015, after his departure from Retrophin. He launched Turing with three drugs in development acquired from Retrophin: An intranasal …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


'Pharma Bro' Martin Shkreli is ordered to return $64M, barred …

(4 days ago) WebShkreli was CEO of Turing Pharmaceuticals — later Vyera — when it jacked up the price of Daraprim from $13.50 to $750 per pill, after obtaining exclusive …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


CEO Who Price Gouged HIV Drug Indicted For Securities Fraud

(7 days ago) WebNEW YORK, Dec 17 (Reuters) - Martin Shkreli, the boyish pharmaceutical entrepreneur who caused a public uproar after he drastically raised the price of a life …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals CEO Martin Shkreli defends 5,000 - CBS …

(Just Now) WebWhen Turing Pharmaceuticals bought the 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


What happened to AIDS drug that spiked 5,000% - CNNMoney

(6 days ago) WebNothing about the drug itself had changed except this: a new company -- Turing Pharmaceuticals -- had bought the rights to distribute it. The Daily Beast dubbed …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Drug CEO Marin Shkreli: Everything You Need to Know Time

(1 days ago) WebIn August, the Shkreli-run company Turing Pharmaceuticals bought an older drug called Daraprim. It’s used to treat a parasitic infection that can be deadly for people with HIV or …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

(7 days ago) WebIt was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the notorious “pharma bro,” jacked up the cost of the lifesaving drug Daraprim by 5,000 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Daraprim Price Hike - Ethics Unwrapped

(Just Now) WebIn 2015, Turing Pharmaceuticals purchased the American marketing rights to Daraprim, the branded version of the drug known generically as pyrimethamine. The drug is on the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs